Elizabeth E. Krans, MD, MSc Assistant Professor, University of Pittsburgh Magee-Womens Research Institute Department of Obstetrics, Gynecology and Reproductive.

Slides:



Advertisements
Similar presentations
Neonatal Abstinence Syndrome: Taking Care of Mom and Baby Heather Rodman, PharmD PGY-2 Pediatric Pharmacy Resident Peyton Manning Children’s Hospital St.
Advertisements

Dosing and patient management requirements during induction, stabilization, and detoxification with buprenorphine Matthew A. Torrington MD Clinical Research.
Effective Risk Management Strategies in Outpatient Methadone Treatment: Clinical Guidelines and Liability Prevention Curriculum Module 9 Special Populations.
Fact sheet Policies and Programs to Address Drug-Exposed Newborns The use or abuse of either illegal or prescription drugs during pregnancy can have serious.
WOMEN’S HEALTH CENTER OF SOUTHERN OREGON * PRIMARYHEALTH OF JOSEPHINE COUNTY Maternal Medical Home.
Treatment of opioid dependence during pregnancy Judith Martin, MD Medical Director The 14 th Street Clinic, Oakland
Moms on Meds Substance Abuse During Pregnancy: Jennifer Anderson Maddron, M.D.
Pharmacological Treatment of Opioid Dependence during Pregnancy: Methadone and Buprenorphine Overview Karol Kaltenbach, PhD Maternal Addiction Treatment.
Drugs and the Fetus Ashley McArdle Tahnee Seibert Holly Horkman.
Neonatal Abstinence Syndrome. Risks for developing NAS Opioids – Opiate derivatives, interact with mu-opioid receptor Abstinence syndrome (withdrawal)
Swinomish Wellness Program
University Hospital “Sisters of Charity” Psychiatric Clinic Vinogradska c. 29, 1000 Zagreb, Croatia Davor Moravek Addiction and psychotic.
John R. Kasich, Governor Tracy J. Plouck, Director Andrea Boxill, Deputy Director Andrea Boxill, Deputy Director Governor’s Cabinet Opiate Action Team.
Sharon Levy, MD, MPH Children’s Hospital Boston
Characteristics of Patients Using Extreme Opioid Dosages in the Treatment of Chronic Low Back Pain In this sample of 204 participants, 70% were female,
EFFECTIVE INTERVENTIONS FOR NEWBORNS WITH DRUG EXPOSURE AND THEIR FAMILIES Harolyn M.E. Belcher, M.D., M.H.S. Associate Professor of Pediatrics Johns Hopkins.
Substance Use & Abuse in Pregnancy Janet L. Mitchell, M.D., M.P.H., F.A.C.O.G. Consultant on Women’s Health Addiction Research & Treatment Corporation.
Emotional and Psychiatric Barriers to Addressing HCV Joan E. Zweben, Ph.D. Executive Director: 14 th Street Clinic and East Bay Community Recovery Project.
For Pain or Not for Pain: Methadone Madness
INFANT BIRTH OUTCOMES AMONG SUBSTANCE USING WOMEN: WHY QUITTING SMOKING IS JUST AS IMPORTANT AS QUITTING HARDER DRUGS Beth Bailey, PhD; Judy McCook, PhD,
Current Trends In Identifying And Treating Newborns With Withdrawal Syndromes 6/24/2010.
Buprenorphine Therapy in Primary Care: One Prescriber’s Experience Pittsburgh, PA August 24, 2005 Melinda Campopiano, M.D. Baron Edmond de Rothschild Chemical.
Drug Treatment Issues in Drug-Dependent, Pregnant Women Hendrée E. Jones, Ph.D. Department of Psychiatry and Behavioral Sciences Johns Hopkins University.
 John McCarthy, M.D.  Executive/Medical Director, Bi-Valley Medical Clinic, Sacramento.
Pregnancy and Drug Abuse Eva Janecek-Rucker. Learning Objectives 1.To develop a knowledge base of the effects of substances of abuse (e.g., alcohol, cocaine,
Module IV: Identification of Patients for Buprenorphine Treatment BUPRENORPHINE TREATMENT: A Training For Multidisciplinary Addiction Professionals.
Intimate Partner Violence During Pregnancy: Arguing As a Risk Factor in a Population-Based Survey Kenneth D. Rosenberg, MD, MPH (a,b), Katherine D. Woods,
Treating Pregnant Opioid Dependent Women: Examining Buprenorphine and Methadone Hendrée E. Jones, Ph.D. Associate Professor Department of Psychiatry and.
 Methadone is prescribed to relieve moderate to severe pain that has not been relieved by non-narcotic pain relievers.
Problem Behaviors Norman Wetterau. Less serious Ran of out pills three days early After one year lost pills Had a headache and a friend gave her a vicodin.
Treatment of Opioid Dependency in Pregnancy and Strategies to Reduce Neonatal Abstinence Syndrome.
Special patient groups Module 5. Introduction Worldwide, the majority of people in substitute treatment are men between Even they do not form a.
The Heroin Epidemic in rural Maryland Rural Health Learning Collaboration Sept. 28, 2015 James A. Cockey, MD, FACP Deputy Health Officer.
Don Teater MD Medical Advisor National Safety Council Itasca, IL Medical Provider Behavioral Health Group Asheville, NC Medical Provider Meridian Behavioral.
Ten Years of Pharmacotherapy Trials in the CTN: An Overview.
SARAH M. BAGLEY, MD ASSISTANT PROFESSOR OF MEDICINE AND PEDIATRICS BOSTON UNIVERSITY SCHOOL OF MEDICINE AMERSA ANNUAL CONFERENCE NOVEMBER 5, 2015 Overdose.
Prevention, Identification and Treatment of Opioid Use Disorders: A Personal Perspective Leah Bauer, MD Medical Director, Addiction Resource Center, Mid.
Addressing the drug affected infant population and tools to end destructive cycles  Amy Baumann- BSW- Safe Babies Healthy Families  Colleen Allen- MSW,
RISE Recovery & Integration Service Substance Use & Pregnancy Liz Thompson Families and Communities Manager.
Risk Factors for Preterm Birth and Low Birth Weight in a Family Medicine Residency Clinic Craig P. Griebel, M.D., Jean C. Aldag, Ph.D. University of Illinois.
Abusing Drugs During Pregnancy is Child Abuse Hannah Magyar CP English 12 Mrs. Mahoney May 5, 2015.
Conclusions Background Objective Results Methods This study was supported by funding from the Scaife Family Foundation, the National Institutes of Health.
Neonatal Abstinence Syndrome: Preserving the Infant-Maternal Bond Haneme Idrizi, MD, FAAP Assistant Professor of Pediatrics, University of Texas Health.
Neonatal Abstinence Syndrome
Specific issues in drug use and pregnancy. Pregnant women who use drugs (RCOG, 2010) One of the challenges for pregnant women who use drugs is that they.
Suboxone and Opioid Trends Joseph Merrill M.D., M.P.H. University of Washington June 16, 2009.
Antenatal Case Study Serah Mungai & Hywel Mackey.
Substance Exposed Newborns: Addressing Substance Use Disorder
Examining Potential Misuse of Gabapentin Among Patients Admitted to an Inpatient Behavioral Health Unit Samuel Kubas a, Pharm.D. Candidate 2018; Lucas.
Special Populations: Opioids and OB Patients(1)
Opioid Use Disorder and pregnancy seminar
Mary Beth Sutter, MD Hannah Watson, MD Sherry Weitzen, MD PhD
Medication-Assisted Therapy at Coleman Profession Services
Neonatal Abstinence Syndrome: An emerging issue for Part C systems?
Opioids – A Pharmaceutical Perspective on Prescription Drugs
Delaware Dialogue: Addressing Substance Abuse DHMIC Summit 2017
University of Pittsburgh
Medication Assisted Treatment and Pregnancy
Treatments for Addiction
Controlled substance compliance
Assessing Opioid Use Disorder, part 1
Mat in a tribal health clinic
30-40% of pregnant women receive opioid
Copyright Notice This presentation is copyrighted by the Psychopharmacology Institute. Subscribers can download it and use it for professional use. The.
Interdisciplinary Treatment for Opioid Use Disorder in the UAMS Women’s Mental Health Program – A Case Study Michael A. Cucciare, PhD and Shona Ray-Griffith,
Case 1 – 17 yo white female 2 year history of using opioids – prescription post minor surgery, continued use post prescription (non-medical sources) –
Treating and Managing Opioid Use Disorder in Pregnancy
Tapering and Discontinuing Chronic Opioid Therapy
Dr. Sarah Fernandez PGY4 NOSM, Pediatrics, Thunder Bay Campus
Presentation transcript:

Elizabeth E. Krans, MD, MSc Assistant Professor, University of Pittsburgh Magee-Womens Research Institute Department of Obstetrics, Gynecology and Reproductive Sciences Patient-Provider Communication Regarding Opioid Use Disorders during the First Obstetric Visit

Opioid Dependence in Pregnancy

Maternal Morbidity 65% have co-occurring psychiatric disorders 77-95% smoke tobacco 35% co-occuring substance abuse o marijuana, cocaine and benzodiazepines 40-75% are HCV positive, 1-4% HIV positive Lack of effective social support, family dysfunction, incarceration, violence and victimization

Neonatal Morbidity 30% rate of preterm birth (< 37 weeks gestation) Significantly more likely to be low birth weight (<2500 grams) 60-80% develop neonatal abstinence syndrome (NAS) Often require admission to the NICU and prolonged treatment

Objective To evaluate patient-provider communication regarding opioid use disorders during the first obstetric visit.

Talking about Substance Use in Pregnancy Secondary analysis of a larger patient-provider obstetric communication study. First obstetric visits between 453 pregnant patients and their obstetric providers were audio recorded to identify patients who disclosed a history of substance use. Patient and providers were blinded to the study purpose. Urine drug screens were sent for 422/453 (93.1%) patients (not recorded in medical record).

Talking about Opioid Use in Pregnancy Among 453 total study patients, 38 (8.4%) admitted a history of opioid use during their audio-recorded visit. Of these patients, 100% were Caucasian, 45% were single, 24% had less than a high school education and 69% made less than $10,000/year. 28 (73.7%) used methadone, 3 (7.9%) used buprenorphine + naloxone, 4 (10.5%) used buprenorphine and 3 (7.9%) used illicit opioids. Urine drug screens were sent for 30 (78.9%) OD patients.

Disclosing Opioid Use in Pregnancy. Disclosure and results of urine drug screen (UDS) for pregnant women using opiates (n=30) UDS ResultsN (%) Disclosed current substance use No disclosure of substance use Methadone only20 (4.7)20-- Opiates only2 (0.5)--2 Methadone + marijuana4 (0.9) 3 methadone 3 marijuana 1 methadone 1 marijuana Methadone + benzodiazepines1 (0.2) Methadone and benzodiazepines -- Methadone + cocaine1 (0.2)MethadoneCocaine Methadone + marijuana + amphetamines 1 (0.2)Methadone Marijuana, amphetamines Methadone + opiates + marijuana1 (0.2)Methadone, marijuanaOpiates

Medical Aspects of Opioid Use CodeDefinitionExample OMT Logistics The dose of OMT, the clinic where they receive their OMT, the MD who prescribes their OMT Pr: What is the dose? Pt: 95 Pr: Ok, and that is through Pyramid? OMT Side Effects Constipation, nausea, GERD Pr: So methadone itself is obviously constipating as is pregnancy so you have a double whammy. So I’d be surprised if you are pooping at all without anything. OMT History Length of time they have been on OMT, different types of OMT they have used, OMT in prior pregnancies Pr: How long have you been on Methadone? Opioid Use Past illicit opioid use, how they became addicted/dependent on opioids, recommendations from providers to not continue to use illicit opioids during pregnancy Pt: Thru a doctor, like I’ve never done heroine or anything like that. Ever. They just had me on so… like they just kept increasing it and increasing it and going up and changing it and then I’m like why am I taking it to begin with. I actually went on vacation with my family and I couldn’t refill it early, you know, because they are narcotics. Illicit Drug Use Past or current illicit drug use other than opiate use (i.e. cocaine, benzos, MJ etc.), provider recommendations to not use illicit drugs while pregnant Pr: Any other drugs that you use? Marijuana, heroin cocaine? Tobacco Use Discussions related to tobacco use (quantity, frequency), tobacco cessation Pr: How much are you smoking these days? Pt: Well like a pack will last me 2 days or 3. Pr: Ok Pt: It is really bad on top of the methadone.

Medical Aspects of Opioid Use

Pregnancy and OMT CodeDefinitionExample Need to stay on OMT during pregnancy Discussions regarding recommendations to stay on OMT during pregnancy Pr: In general we recommend continuing the methadone when you are pregnant. Because we don’t want you to withdraw from opioids while pregnant…because there is a higher risk for miscarriage and a higher risk for stillborns…so we recommend that people stay on the methadone. Also, people with a history of IV drugs and stuff, it helps to reduce their high-risk behaviors. Pt: Is there any way to do this in a way where I was like weaning myself? Pr: No, not during pregnancy. OMT type in pregnancy Discussions over whether or not to use subutex, suboxone or methadone Pt: the one person I know on methadone is high – they look high all the time. Pr: So, if he is comfortable with that we don’t really have to do anything differently. Pt: I hope so. It would be really hard to get to a methadone clinic. I have a full-time job… a 5 yo. OMT dose in pregnancy Any conversations related to the need to increase dosing in pregnancy Pt: They don’t want me to go up very much now because they are scared, they said that the longer the pregnancy goes on, they said that I’m going to have to keep going up and up because the baby will start taking more and more so they don’t want me to go up now. Pr: What kind of symptoms are you having ? Pt: Like your typical withdrawal symptoms, like at 9:00 pm, I start to not feel very well, but by 11:00, I’ve got the runny nose, the chills, then the sweats.

Pregnancy and OMT

Counseling regarding opioid use CodeDefinitionExample NAS/neonatal implications Any type of counseling regarding NAS, prolonged length of stay for the baby Pr: But you have to be aware…babies are monitored in the hospital after delivery for signs and symptoms of withdrawal and they are usually given medications to treat those symptoms. Breastfeeding Conversations about breastfeedingPr: You know we encourage women to breastfeed. Partner/IPV Any mention of partner, partner support of the pregnancy, IPV Pt: My husband was on it whenever I had my first daughter. My boyfriend doesn’t do drugs at all. Pr: Bring him to the next visit. Do you feel safe with him at home? Legal issues Conversation about incarceration, arrest, probation and/or legal issues Pr: Ok, what is ARD? Pt: It is accelerated rehabilitation disposition. It is like probation. Housing Discussions related to housing, residential support Pr: So, that is where you are living at now? HIV/HCV/IV use Any questions regarding HCV/HIV testing, IV drug use history Pr: Have you had testing recently for HIV or HCV? Psychiatric disorders Any discussion focused on psychiatric diagnoses or treatment Pr: Any other medical issues that you have? Pt: Um, no, besides anxiety and depression and um. Pr: Ok Pt: The methadone, nothing else Pr: Any you were not on any medications early in this pregnancy? Pt: No, um just the methadone…

Counseling regarding opioid use

Conclusions Patient-provider discussions regarding opioid use primarily focused on the medical aspects of opioid use including the type, dose and duration of opioid maintenance therapy. Counseling from obstetric care providers predominantly focused on the neonatal implications of opioid use during pregnancy such as neonatal abstinence syndrome (NAS) and increased neonatal length of stay for NAS. Few providers discussed HIV and Hepatitis C (HCV) testing, risk factors for HIV/HCV transmission such as intravenous opioid use, or discussed important social issues for these patients such as safe housing, social support and available resources.

Thank you Judy Chang, MD, MPH o Study Funded by the National Institute of Drug Abuse (NIDA) 1R01DA A1 (PI – J. Chang), and supported by the National Institutes of Health through Grant Number UL1TR Cyndi Holland, MPH Penelope Morrison, PhD